BRAF and pleomorphic xanthoastrocytoma: According to our results and those of previous studies[42], we emphasize that malignant astroglial tumors with histomorphological and immunohistochemical features of a giant cell glioblastoma, in which a BRAF V600E mutation is detected with a mutation specific antibody or by DNA sequencing should be re-examined to definitely exclude diagnosis of PXA.